Sleep Number Q1 Revenue at $319M, Slightly Below Expectations
Reports Q1 revenue $319M, consensus $320.72M. Linda Findley, President and CEO, commented, "Q1 came in as expected given the soft start to the year, but year-over-year demand improved steadily throughout the quarter, ending with growth in March over last year. We are confident in the early positive metrics we are seeing from our new product launch and marketing campaigns, and the customer feedback on our new beds is fantastic. We believe this, combined with the full realization of our cost savings actions, puts us in line with the financial indications we highlighted in the previous earnings call. "With the additional short-term liquidity provided by our existing lender group, we are fully focused on securing a long-term capital solution and are moving through the process of evaluating a range of strategic and financing options to maximize stakeholder value. I'm proud of the significant progress the team has made on the turnaround, and I believe we have positioned Sleep Number well for future growth."
Trade with 70% Backtested Accuracy
Analyst Views on SNBR
About SNBR
About the author

- Declining Financial Performance: Sleep Number reported Q1 2026 results with a GAAP EPS of -$2.19, missing consensus estimates by $1.72, and revenue of $318.99 million, reflecting an 18.9% year-over-year decline, indicating severe profitability challenges for the company.
- Suspension of Financial Guidance: The company suspended its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, which suggests a proactive approach to address its current financial difficulties.
- Significant Stock Price Drop: Following the earnings report, Sleep Number's stock price fell by $0.55, or 22.45%, closing at $1.90 per share, reflecting investor concerns regarding the company's future outlook and financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, potentially leading to a class action lawsuit, which could further exacerbate market concerns about its governance structure.
- Liquidity Improvement: Sleep Number reached an agreement with existing lenders that adds $55 million in liquidity, including a new $25 million term loan, allowing time to focus on a long-term capital structure solution, thereby alleviating short-term financial pressures.
- Sales Performance Recovery: The company reported net sales of $319 million in Q1, which, while 19% lower year-over-year, aligns with analysts' expectations of $321 million, demonstrating resilience in the market recovery despite macroeconomic uncertainties.
- Product Line Success: The newly launched ComfortNext Lux mattress has become the top-selling product at approximately $4,000, and during the launch period, stores featuring the new lineup saw a 12% higher average revenue per unit (ARU) compared to previous products, indicating positive consumer reception.
- Effective Cost Control: Since the beginning of 2025, the company has identified over $235 million in annualized savings, with $200 million already executed, showcasing effective cost management that supports future profitability enhancements.
- Severe Earnings Loss: Sleep Number reported a Q1 GAAP EPS of -$2.19, missing expectations by $1.72, indicating significant challenges in profitability for the company.
- Revenue Decline: The company generated $318.99 million in revenue for Q1, an 18.9% year-over-year decrease, failing to meet expectations and reflecting pressures from weak market demand and declining sales.
- Adjusted EBITDA Drop: Adjusted EBITDA fell to $6 million, down 74%, primarily driven by a decline in net sales and associated loss of fixed cost leverage, although partially offset by lower operating expenses.
- Deteriorating Cash Flow: Year-to-date, net cash used in operating activities was $8 million, down $5 million from last year, with free cash flow showing a use of $13.2 million, highlighting difficulties in cash flow management.
- Liquidity Agreement: Sleep Number has reached an agreement with lenders to secure $55 million in liquidity, including a $25 million term loan, which provides essential funding to support its turnaround strategy and maintain competitiveness in the market.
- Covenant Relief: The agreement also eases certain financial and liquidity covenants, allowing the company greater flexibility to execute its product and marketing plans, particularly as it approaches the Memorial Day selling season, which is expected to drive sales growth.
- Stock Surge: Sleep Number's shares soared over 34% in premarket trading to $2.97; however, the stock remains more than 75% below its 52-week high, indicating market caution regarding its long-term recovery potential.
- Strategic Restructuring: The CFO highlighted that Sleep Number will continue to prioritize resetting its capital structure while planning to roll out a new product portfolio and marketing campaign to maximize value and attract more consumers.
- New Marketing Campaign: Sleep Number has launched a new integrated marketing campaign titled 'To a Good Life's Sleep,' which emphasizes personalized adjustable comfort, marking a significant phase in the company's brand evolution.
- Strategic Shift: This campaign not only focuses on product features but also highlights user comfort experiences, reflecting the company's shift from feature-centric to benefit-driven marketing strategies, which is expected to enhance its competitiveness in the premium market.
- Brand Awareness Growth: According to the brand tracker completed in January 2026, brand consideration among premium shoppers increased by 10%, indicating the effectiveness of the new marketing strategy, particularly in key drivers such as value, quality, and individualized comfort.
- Product Line Support: The new campaign supports Sleep Number's entire product range, from entry-level options to premium smart beds, ensuring a clear benefit-led narrative across all price points, further solidifying its market leadership.
- Debt Crisis Intensifies: The mattress brand is facing severe challenges due to debt-fueled buyback strategies, with shrinking cash flow leading to deteriorating financial conditions that could impact future operational capabilities.
- Shareholder Risks Rise: As the credit deadline looms, the risks faced by common shareholders significantly increase, potentially leading to a substantial decrease in shareholder value and affecting investor confidence.
- Capital Allocation Missteps: The company's gamble on capital allocation has failed to yield the expected returns, exacerbating financial pressures and forcing management to reassess its strategic direction.
- Negative Market Reaction: The market holds a pessimistic view of the brand's future prospects, which could lead to further declines in stock price, impacting the company's financing capabilities and market competitiveness.










